All In Biotech

Drug Trial Radar · NCT04248465

An Efficacy and Safety Study of Ravulizumab in ALS Participants

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Ravulizumab in Patients With Amyotrophic Lateral Sclerosis (ALS)

Last checked: Nov 20, 2026Latest source record: Jan 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 382 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

382

Actual

Start

Mar 30, 2020

Primary completion

Oct 17, 2021

Study completion Oct 17, 2021

Sponsor

Lead sponsor
Alexion Pharmaceuticals, Inc.AstraZeneca (AZN)
Sponsor type
Industry
First posted
Jan 30, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment of adult participants with ALS.

Conditions

  • Amyotrophic Lateral Sclerosis
  • ALS

Interventions

  • PlaceboDrug

    Single loading dose via intravenous infusion, followed by regular maintenance dosing, based on weight.

  • RavulizumabBiological

    Single loading dose via intravenous infusion, followed by regular maintenance dosing, based on weight.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline In Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) Total ScoreTime frame: Baseline, Week 50

Locations

95 sites in 17 countries. Site status is shown where the registry gives one.

  • Barrow Neurological Institute

    Phoenix, Arizona

  • Neuromuscular Research Center and Clinic

    Phoenix, Arizona

  • HonorHealth Research Institute

    Scottsdale, Arizona

  • Loma Linda University Medical Center

    Loma Linda, California

  • University of Southern California

    Los Angeles, California

  • University of California-Irvine

    Orange, California

  • Stanford University Medical Center

    Palo Alto, California

  • University of California San Diego Medical Center

    San Diego, California

  • Norris MDA/ALS Center

    San Francisco, California

  • University of California San Francisco Medical Center

    San Francisco, California

  • University of Colorado Anschutz Medical Campus School of Medicine

    Aurora, Colorado

  • University of Florida at Shands Jacksonville

    Jacksonville, Florida

  • University of South Florida

    Tampa, Florida

  • University of Chicago Medical Center

    Chicago, Illinois

  • Indiana University Medical Center

    Indianapolis, Indiana

  • University of Kansas Medical Center Research Institute, Inc.

    Kansas City, Kansas

  • University of Kentucky

    Lexington, Kentucky

  • Johns Hopkins University School Of Medicine

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Las Vegas Clinic

    Las Vegas, Nevada

  • Beth Israel Medical Center - PRIME

    New York, New York

  • Hospital for Special Surgery

    New York, New York

  • Atrium Health Neuroscience Institute

    Charlotte, North Carolina

  • The Cleveland Clinic Foundation

    Cleveland, Ohio

  • The Ohio State University

    Columbus, Ohio

  • Allegheny Neurological Associates

    Pittsburgh, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Austin Neuromuscular Center

    Austin, Texas

  • Houston Methodist Neurological Institute-Movement Disorders Clinic

    Houston, Texas

  • Nerve & Muscle Center of Texas

    Houston, Texas

  • University of Vermont Medical Center

    Burlington, Vermont

  • Virginia Commonwealth University, Neurology Clinical and Translational Research Office

    Richmond, Virginia

  • Sentara Neurology Specialists

    Virginia Beach, Virginia

  • Swedish Neuroscience Institute

    Seattle, Washington

  • Brain and Mind Centre

    Camperdown, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Royal Brisbane and Women's Hospital

    Herston, Queensland, Australia

  • Perron Institute for Neurological and Translational Science

    Nedlands, Western Australia, Australia

  • UZ Leuven

    Leuven, Belgium

  • Heritage Medical Research Centre (HMRC)

    Edmonton, Alberta, Canada

Showing 40 of 95 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.